We examined the degree of hepatic iron overload in patients receiving marrow transplant for hematologic malignancy and evaluated a new method of morphometric analysis of marrow iron content as a means of estimating hepatic iron stores in these patients. The iron content of marrow and liver specimens from 10 consecutive patients who died between 50 and 100 days after transplant was determined by spectrophotometry. Their mean age was 34.9 years (range 10-59). The mean time to death from disease onset was 2.2 years (0.5-8.7). Patients had received 30.2 ± ± ± 17.4 units of red cells during the transplant period and 47.6 ± ± ± 25.9 red cell units from diagnosis to death. The median hepatic iron concentration (HIC) was 4307 g/g dry weight (range 1832-13120; normal 530-900) and the median hepatic iron index (HIC (mol/g dry weight/age (years)) was 3.85 (0.76-8.14). The median biochemical marrow iron content was 1999 g/g dry weight (range 932-3942). Morphometric analysis of the marrow iron content was performed on digital photomicrographs of a single Prussian blue-stained section of marrow. Strong correlations were demonstrated between morphometric marrow iron content and (1) biochemical marrow iron content (r = 0.8, P = 0.006) and (2) biochemical hepatic iron index (r = 0.82, P = 0.004). We conclude that marrow transplant recipients have a high liver iron content at 50-100 days post transplant with the hepatic iron index in the hereditary hemochromatosis range. Computerized morphometric marrow iron determination is a readily available means of estimating hepatic iron stores in these patients.
hematologic malignancy, are also often heavily transfused and commonly have histologic evidence of moderate to marked siderosis on liver biopsy following the procedure. 4, 5 However, there are limited data on objective quantitation of liver iron content after marrow transplantation for hematologic malignancy. Furthermore, the consequences of excess tissue iron in non-thalassemic patients who survive marrow transplantation have not been clearly defined, although a role in both short-and long-term hepatic dysfunction [5] [6] [7] [8] appears likely. The aims of this study were to examine the degree of hepatic iron overload in patients receiving bone marrow transplantation for hematologic malignancy and to evaluate a new method of morphometric analysis of marrow iron content as a means of estimating hepatic iron stores in these patients. Apart from liver biopsy, there is no accurate, readily available means to quantitate the tissue iron stores of patients after a successful bone marrow transplant. Serum ferritin levels may be unreliable in such patients, because of the effects of acute inflammation and liver dysfunction. 9 Because marrow aspirates are performed routinely before patients are discharged home post-transplant, the measurement of marrow iron might be an inexpensive, simple way of gauging the body's iron burden. This measure of iron overload would be suitable both for epidemiologic studies of historical marrow transplant patients and for screening for iron overload in current patients after a successful marrow transplant.
Materials and methods

Patient selection
Ten consecutive patients who died between 50 and 100 days following allogeneic or syngeneic bone marrow transplantation and who underwent autopsy at our Center from June 1995 to April 1996 were studied. Consent for complete autopsy was obtained from family members and the protocol for study of iron stores was approved by the FHCRC Institutional Review Board.
The autopsy protocol at the FHCRC includes sampling of all body organs with storage of formalin-or B5-fixed specimens as paraffin blocks. Several 1 cm 3 sections of liver are routinely fixed in 10% buffered formalin, and embedded in paraffin. As one means of storing autopsy bone marrow specimens, sections of rib (0.5 cm in length) are fixed in B5 and embedded in paraffin. Samples of liver and bone marrow from each patient were obtained from the FHCRC archive and used in this study.
The medical record of each patient was analyzed for demographic data, pre-transplant information including transfusion history and HLA status, and transplantationrelated events.
Biochemical iron quantitation in tissue
Tissue iron content was quantitated using a spectrophotometric method. 10 Paraffin-embedded liver and bone marrow samples, weighing at least 0.4 mg, were cut from paraffin blocks, washed twice in xylene, dried (Savant Speedvac, Savant Instruments, Farmingdale, NY, USA), weighed, digested in concentrated nitric acid at 65-75°C for 10-15 min and adjusted to pH 4.5. The iron concentration was determined by bichromatic endpoint on the Dimension AR Spectrophotometer (Dupont Instruments, Wilmington, DE, USA) using disodium 3-(2-pyridyl)-5,6-bis-2(5-furyl sulfonic acid)-1,2,4-triazene (Ferene) as the chromogen. 11 The laboratory reference range for liver iron concentration is 530-900 g/g dry weight.
The biochemical hepatic iron index was determined by the formula: liver iron concentration (mol/g dry weight)/age (year). 12 The marrow iron concentration determined biochemically was expressed as g Fe per gram dry weight and corrected for the hydroxyapatite content of the sample to account for any contaminating bone material. No reference range exists in this laboratory for marrow iron content.
Morphometric determination of bone marrow iron content
One 5 m section of each patient's paraffin-embedded bone marrow, immediately subjacent to the sample used for biochemical iron quantitation, was stained with Perl's Prussian blue (potassium ferrocyanide) with nuclear red as a counterstain. The marrow sections from all 10 patients were stained by a single technician in one batch. A digital camera (Kodak Professional DCS 420c; Eastman Kodak Company, Rochester, NY, USA) mounted on a microscope (Labophot, Nikon Corporation, Tokyo, Japan) was used to photograph 10 separate marrow fields from each patient's section using an objective magnification of ×10. Using the software program, Adobe Photoshop 2.5 (Adobe Systems Incorporated, San Jose, CA, USA), each of the 10 images were transferred to a Macintosh computer (Power Macintosh 7200/90; Apple Computer, Cupertino, CA, USA) and the individual color channels (red, green and blue) separated. The bluestaining iron particles were enhanced in the red channel and minimized in the green channel. The public domain image analysis program, NIH Image 1.60 (developed at the US National Institutes of Health and available on the Internet at http://rsb.info.nih.gov/nih-image/), was used to quantitate (1) the total area comprising iron particles and (2) the total area of nucleated cells (to normalize for marrow cellularity). This was achieved by adjusting the threshold level to first discriminate enhanced iron particles from the surrounding marrow and second, the enhanced hemopoietic cell nuclei from bone fragments and fat.
A mean value of determinations from 10 marrow fields was calculated to obtain the average area of iron particles and the average area of hemopoietic nuclei for each patient's marrow section. The average area of iron particles was then expressed as a percentage of the average area of hemopoietic nuclei, and termed the morphometric marrow iron content.
To exclude intra-observer variability in the threshold levels set for quantitation, the assay was performed twice on the same 10 digital photomicrographs from each subject. The investigator (SIS) performing the morphometric assays was blinded to the results of biochemical iron assays.
Statistical analysis
Simple linear regression analysis of the relationships between biochemical and morphometric determinations of tissue iron measures and the Wilcoxon signed rank test for comparison of repeated measures were performed using the software program, StatView 4.0 (Abacus Concepts, Berkeley, CA, USA).
Results
Clinical characteristics
The clinical characteristics of the 10 patients are shown in Table 1 . The majority of patients were young adults at the time of transplant (mean age ± s.d., 34.9 ± 15.5 years; range 10-59). None had a medical history or family history consistent with hereditary hemochromatosis. The mean time to death from first onset of hematologic disease was 2.2 years (range 0.5-8.7) and from transplant was 73 days (range 50-99). Three patients received bone marrow transplant for myelodysplasia complicating another longer standing disease process or its treatment (congenital neutropenia, breast adenocarcinoma, non-Hodgkin's lymphoma). Three patients had received a second transplant, a procedure associated with a high mortality rate. The patients had a history of receiving a large number of red cell transfusions both during the transplant period (mean ± s.d., 30.2 ± 17.4 units), and from the time of diagnosis of their hematologic disorder to death (47.6 ± 25.9 units). Seven of the eight patients receiving allogeneic transplants died from complications of severe graft-versus-host disease. No patient had significant hepatic fibrosis or cirrhosis present at autopsy.
HLA-A3 status
Patients with hereditary hemochromatosis have an increased frequency of the HLA-A3 allele compared to the normal population. 13 Seven of the 10 patients in this study were heterozygous for HLA-A3 although there was no significant difference between the hepatic iron index (see below) of the HLA-A3-positive patients compared to those without this allele. In fact, the two patients with the highest hepatic iron indices (9303 and 9391) were HLA-A3 negative. Genetic analysis was not performed for mutations in the recently described HFE gene, 14 which are found in the majority of patients with hereditary hemochromatosis. 
Biochemical quantitation of tissue iron stores
The results of biochemical quantitation of liver and marrow iron content are shown in Table 2 . All patients had a hepatic iron content at least twice the upper limit of normal. The median value was five times the upper limit of normal. A seven-fold variation in levels was present. The median hepatic iron index was 3.85 with six of the 10 patients having an index greater than 1.9, the cut-off level utilized in the diagnostic work-up for hereditary hemochromatosis. It was not possible to relate the results of biochemical marrow iron determination to that found in normal individuals, as no reference range exists. The median value for marrow iron concentration seen in this study, normalized for the hydroxyapatite content of the bone sample, was 1998.5 g Fe/g dry weight (range 932-3942).
There was no correlation between biochemically determined iron content of liver or bone marrow and the total number of transfused red cells in this study population. 
Image analysis of stained marrow sections
All patients in this series had iron particles present in stained marrow sections. A digital photomicrograph of a section of bone marrow stained with Perl's Prussian blue (×10 original magnification) is shown ( Figure 1a ). Marrow iron can be clearly seen as darkly staining particles. Also shown are the computer-generated images of the same field, which have been threshold adjusted to allow quantitation of the background cellularity (Figure 1b ) and the individual iron particles (Figure 1c) . The values obtained for morphometric marrow iron content for individual patients are displayed in Table 2 .
There was no significant difference, by Wilcoxon ranked sign test, between two sets of observations for morphometric marrow iron content. The red channel image was acquired into NIH image and the threshold level adjusted to display only iron particles. The total area comprising iron particles was determined and expressed relative to the total cellular area (results shown in Table 2 ).
Relationship between marrow iron (by morphometrics) and marrow and liver iron (by biochemical determination)
A highly significant correlation was present on linear regression analysis between the morphometrically determined marrow iron content and the biochemically determined marrow iron content (r = 0.80, P = 0.006) (Figure 2) . A strong correlation was also found between the morphometric marrow iron content and the biochemical hepatic iron index (r = 0.82, P = 0.004), supporting the hypothesis of a relationship between marrow and hepatic iron stores in patients with secondary iron overload ( Figure 3 ).
Discussion
Over 30 years ago, a close relationship between biochemical concentration and histologic grading of marrow iron was demonstrated. 15 As histologic grading is subject to substantial variation between and within observers, 16 we sought to develop a computerized method for quantitation of iron in histologic sections. The advantages of the morphometric assay described in this study are that it can be performed on a single stained section of marrow, a specimen routinely available in patients with hematologic malignancy, using computer equipment and software readily available to any investigator 17 and at little expense. We have demonstrated a strong correlation between biochemical marrow iron content and morphometric marrow iron, supporting the use of this method in quantitating the amount of iron in bone marrow. A similar morphometric method for determination of tissue iron stores has been applied to liver sections. 18, 19 In those studies a close correlation was also observed between biochemically determined hepatic iron content and computerized image analysis as well as with histologic grade of iron overload.
Patients receiving a bone marrow transplant for hematologic malignancy or aplastic anemia commonly develop hepatic iron overload. In previous reports, a diagnosis of iron overload after marrow transplantation has been based on an elevated serum ferritin, found in 67/76 (88%) of 1 year survivors, 7 or on histologic evidence of siderosis, found in 20/22 (91%) of liver biopsies performed at 15-110 days post transplant. 4 However, the serum ferritin level may be a poor measure of liver iron concentration in this setting 20 and a histologic grading system at best only semiquantitative and subject to inter-observer error. Possibly because of the risks of liver biopsy in thrombocytopenic patients, biochemical quantitation of hepatic iron stores after marrow transplantation has not been reported.
In this autopsy series, we have demonstrated that at 50-100 days after marrow transplantation for hematologic malignancy, patients commonly have hepatic iron indices in the range seen in hereditary hemochromatosis. The ageadjusted hepatic iron index was originally described to distinguish between patients with hereditary hemochromatosis (in whom iron accumulates progressively from birth) and those with milder iron overload associated with alcoholic liver disease or heterozygosity for hereditary hemochromatosis. 12 However, it has come to be used by clinicians as the primary means of distinguishing between hereditary hemochromatosis and other forms of iron overload. In bone marrow transplant recipients, time-adjustment of the hepatic iron content provides important information as it reflects pre-transplant iron accumulation often due to many years of dyserthropoiesis, increased intestinal iron absorption and multiple red cell transfusions. As shown in this study, bone marrow transplant recipients have similar amounts of hepatic iron accumulation as hereditary hemochromatosis patients, although it is not known if the longterm risks of cirrhosis and hepatocellular carcinoma are increased to a similar degree. This is a particular concern, as many of these patients are children or young adults at the time of their transplant.
The image analysis-based method for quantitation of marrow iron stores described here provides a simple means of estimating hepatic iron overload after marrow transplantation. We have demonstrated that the morphometric marrow iron strongly correlates with the biochemical hepatic iron index which is the current gold standard measure of hepatic iron overload. A relationship between marrow and liver iron content in patients with secondary or transfusional iron overload has previously been reported, 15, 21, 22 however, no relationship exists in patients with primary iron overload (hereditary hemochromatosis). 21 It is to be expected therefore, that the method described would provide an estimate of hepatic iron stores only in situations where iron accumulates primarily in the reticuloendothelial cells, such as after marrow transplantation, and would not be valid in the assessment of hereditary hemochromatosis patients.
It might be argued that the tissue iron stores of patients dying at 50-100 days post transplantation may not be representative of those in patients surviving beyond that period. Certainly, in comparison with patients who have few complications, patients with multiple transplant-related complications, such as severe graft-versus-host disease, graft failure or intestinal bleeding, have a much higher red cell transfusion requirement. However, in this study, no correlation was found between the total number of transfused red cell units and tissue iron content, suggesting that other factors, including dyserythropoiesis leading to increased intestinal iron absorption, are also important. 6, 23 It should be noted that 8/10 patients in this series had received 50 or fewer red cell units since diagnosis of their hematologic disease. This level of transfusion is much lower than the 100-150 units of blood generally considered necessary for iron-induced tissue damage. 24 In these patients dying at 50-100 days, no fibrosis or cirrhosis was seen.
Iron overload may be associated with a number of consequences, some of which may adversely affect the shortterm course of marrow transplant recipients. Iron overload may be a cause of persistent hepatic dysfunction after marrow transplantation, 6, 8 possibly due to a combination of acute toxic effects with free radical formation and lipid peroxidation of membranes, 25, 26 the effects of intracellular iron accumulation. 27 Patients with hepatic iron overload, particularly if they are also immunocompromised, are at increased risk of a variety of opportunistic infections wich such organisms as Yersinia enterocolitica, 28 Listeria monocytogenes, 29 mucormycosis 30 and non-cholera vibrio species. 31 In fact in this study, two patients (with hepatic iron concentrations of three and 14 times the upper limit of normal) died from disseminated mucormycosis, a relatively rare complication of marrow transplantation. 32 Iron overload may also adversely affect hemopoiesis. 33 In the longer term, hepatic iron overload may worsen the natural history of chronic viral liver disease, particularly chronic hepatitis C, and adversely affect response to antiviral therapy. 34 After many years, iron overload may lead to progressive hepatic fibrosis, cirrhosis and hepatocellular carcinoma as has been well documented in thalassemics, 35 hemodialysis patients, 36 and patients with hemotologic malignancy. 23 Non-hepatic consequences of iron overload include multiple endocrine abnormalities, growth failure and cardiac disease. Routine assessment of tissue iron stores after transplantation, followed by phlebotomy in those with iron overload, has recently been proposed, 8, 37 an approach which can lead to improved liver enzymes. 7 An evaluation of tissue iron stores should be included in the routine assessment of all patients after marrow transplantation because of the potential adverse consequences of untreated iron overload. Effective therapy, in the form of phlebotomy or chelation, is readily available and should be offered to those patients who are found to have significant iron overload. Morphometric analysis of marrow iron content may provide a simple, reliable and inexpensive means of identifying patients requiring further assessment by liver biopsy. Furthermore, with the ability to apply this methodology to paraffin-embedded bone marrow sections, the potential exists to investigate the role of iron overload in subsequent organ dysfunction, by evaluating the iron content of marrow sections stored at the time of posttransplant assessment.
